Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Stephen Spurgeon is an Associate Professor and Section Head of Hematologic Malignancies at Knight Cancer Institute. He received his MD from Jefferson Medical College (now Sidney Kimmel Medical College) at Thomas Jefferson University in Philadelphia. Dr. Spurgeon continued his training in internal medicine at OHSU, where he also served as Chief Resident. Subsequently, he completed his fellowship in Hematology and Medical Oncology at OHSU. He continues to specialize in the care of patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma at CHM and at the KCI East Portland Office. Dr. Spurgeon collaborates with a number of colleagues at the KCI to better define therapeutic targets and develop targeted therapies across a number of blood cancers.